Drug Profile
Glycovir
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antivirals
- Mechanism of Action Alpha-glucosidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 22 May 2001 Profile reviewed but no significant changes made
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 25 Aug 1995 Investigation in HIV infections treatment in USA (Unknown route)